Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Mier

Showing results (121-130 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2019
Development and dosimetry of <sup>203</sup>Pb/<sup>212</sup>Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Preclinical evaluation of the breast cancer cell-binding peptide, p160Vasileios Askoxylakis, Sabine Zitzmann, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Response Prediction of <sup>177</sup>Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate DehydrogenaseHendrik Rathke, Tim Holland-Letz, Walter Mier, et al.
Oncotarget|July 26, 2018
Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapyClaudius Melzig, Azadeh Fahim Golestaneh, Walter Mier, et al.
Bioconjugate Chemistry|August 9, 2017
Improving the Imaging Contrast of <sup>68</sup>Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic PropertiesAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Gels (Basel, Switzerland)|August 28, 2024
In Vitro Physicochemical and Pharmacokinetic Properties of Bevacizumab Dissolved in Silicone Oils Compared to Hydrogel-Substitutes and Porcine Vitreous BodiesMaximilian Hammer, Jonathan Herth, Lorenz Herbster, et al.
Investigative Ophthalmology & Visual Science|July 14, 2026
Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT StudySabrina Wohlfart, Hellen Gertrud Roettgen, Niklas Junker, et al.
Pharmaceuticals (Basel, Switzerland)|June 4, 2020
Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant EnterococciEric Mühlberg, Florian Umstätter, Cornelius Domhan, et al.
Clinical Science (London, England : 1979)|December 16, 2014
Generation of suppressive blood cells for control of allograft rejectionChristian Kleist, Flavius Sandra-Petrescu, Lucian Jiga, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2023
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrierJulia Werner, Florian Umstätter, Tobias Hertlein, et al.
Pageof 19

Showing results (121-130 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|January 4, 2019
Development and dosimetry of <sup>203</sup>Pb/<sup>212</sup>Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Preclinical evaluation of the breast cancer cell-binding peptide, p160Vasileios Askoxylakis, Sabine Zitzmann, Walter Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 27, 2019
Response Prediction of <sup>177</sup>Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate DehydrogenaseHendrik Rathke, Tim Holland-Letz, Walter Mier, et al.
Oncotarget|July 26, 2018
Combined external beam radiotherapy with carbon ions and tumor targeting endoradiotherapyClaudius Melzig, Azadeh Fahim Golestaneh, Walter Mier, et al.
Bioconjugate Chemistry|August 9, 2017
Improving the Imaging Contrast of <sup>68</sup>Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic PropertiesAnn-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, et al.
Gels (Basel, Switzerland)|August 28, 2024
In Vitro Physicochemical and Pharmacokinetic Properties of Bevacizumab Dissolved in Silicone Oils Compared to Hydrogel-Substitutes and Porcine Vitreous BodiesMaximilian Hammer, Jonathan Herth, Lorenz Herbster, et al.
Investigative Ophthalmology & Visual Science|July 14, 2026
Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT StudySabrina Wohlfart, Hellen Gertrud Roettgen, Niklas Junker, et al.
Pharmaceuticals (Basel, Switzerland)|June 4, 2020
Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant EnterococciEric Mühlberg, Florian Umstätter, Cornelius Domhan, et al.
Clinical Science (London, England : 1979)|December 16, 2014
Generation of suppressive blood cells for control of allograft rejectionChristian Kleist, Flavius Sandra-Petrescu, Lucian Jiga, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2023
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrierJulia Werner, Florian Umstätter, Tobias Hertlein, et al.
Pageof 19